Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review
Authors
Keywords
Metastatic, Renal cancer, Cytoreductive nephrectomy, Targeted therapy
Journal
WORLD JOURNAL OF UROLOGY
Volume 35, Issue 12, Pages 1807-1816
Publisher
Springer Nature
Online
2017-07-12
DOI
10.1007/s00345-017-2072-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytoreductive Nephrectomy in the Tyrosine Kinase Inhibitor Era: A Question That May Never Be Answered
- (2017) Grant D. Stewart et al. EUROPEAN UROLOGY
- Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness
- (2017) Daniel J. Serie et al. EUROPEAN UROLOGY
- CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma
- (2017) Bernard Escudier et al. EUROPEAN UROLOGY
- Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based Analysis
- (2017) Boris Gershman et al. JOURNAL OF UROLOGY
- The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma: Prognostic features in the era of targeted therapies
- (2017) Tom Claeys et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapy
- (2016) Emiliano Calvo et al. CANCER TREATMENT REVIEWS
- Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: A Systematic Review With a Meta-Analysis
- (2016) Fausto Petrelli et al. Clinical Genitourinary Cancer
- Mortality trends and the impact of lymphadenectomy on survival for renal cell carcinoma patients with distant metastasis
- (2016) Hiten D. Patel et al. CUAJ-Canadian Urological Association Journal
- The Role of Cytoreductive Nephrectomy: European Association of Urology Recommendations in 2016
- (2016) Axel Bex et al. EUROPEAN UROLOGY
- Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy
- (2016) Boris Gershman et al. EUROPEAN UROLOGY
- Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study
- (2016) Nawar Hanna et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival in Patients With Primary Metastatic Renal Cell Carcinoma Treated With Sunitinib With or Without Previous Cytoreductive Nephrectomy: Results From a Population-based Registry
- (2016) Saskia de Groot et al. UROLOGY
- Minimally invasive cytoreductive nephrectomy: a multi-institutional experience
- (2016) Luciano Nunez Bragayrac et al. WORLD JOURNAL OF UROLOGY
- Perioperative outcomes of cytoreductive nephrectomy in the UK in 2012
- (2015) Benjamin L. Jackson et al. BJU INTERNATIONAL
- A Systematic Review of Sequencing and Combinations of Systemic Therapy in Metastatic Renal Cancer
- (2015) Laurence Albiges et al. EUROPEAN UROLOGY
- EAU Guidelines on Renal Cell Carcinoma: 2014 Update
- (2015) Borje Ljungberg et al. EUROPEAN UROLOGY
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Surgical considerations for patients with metastatic renal cell carcinoma
- (2015) Mehrad Adibi et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features
- (2015) Romain Mathieu et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The use of prognostic factors in metastatic renal cell carcinoma
- (2015) Haoran Li et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Prognostic Significance of Cytoreductive Nephrectomy in Patients With Synchronous Metastases From Renal Cell Carcinoma Treated With First-Line Sunitinib: A European Multiinstitutional Study
- (2014) Aristotle Bamias et al. Clinical Genitourinary Cancer
- Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
- (2014) Daniel Y.C. Heng et al. EUROPEAN UROLOGY
- Lymph node dissection during cytoreductive nephrectomy: A retrospective analysis
- (2014) Michael A Feuerstein et al. INTERNATIONAL JOURNAL OF UROLOGY
- Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005–2010: a population-based study from the National Swedish Kidney Cancer Register
- (2014) Andreas Thorstenson et al. Scandinavian Journal of Urology
- Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell carcinoma (RCC)
- (2013) Ayal A. Aizer et al. BJU INTERNATIONAL
- Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era
- (2013) Simon L. Conti et al. INTERNATIONAL JOURNAL OF CANCER
- External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
- (2013) Daniel YC Heng et al. LANCET ONCOLOGY
- Effect of Nodal Metastases on Cancer-specific Mortality After Cytoreductive Nephrectomy
- (2012) Quoc-Dien Trinh et al. ANNALS OF SURGICAL ONCOLOGY
- Systematic classification and prediction of complications after nephrectomy in patients with metastatic renal cell carcinoma (RCC)
- (2012) Jonathan L. Silberstein et al. BJU INTERNATIONAL
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Trends in the Use of Cytoreductive Nephrectomy in the United States
- (2012) Che-Kai Tsao et al. Clinical Genitourinary Cancer
- In-hospital Mortality and Failure to Rescue After Cytoreductive Nephrectomy
- (2012) Quoc-Dien Trinh et al. EUROPEAN UROLOGY
- Clinical and Molecular Prognostic Factors in Renal Cell Carcinoma: What We Know So Far
- (2011) Patricia A. Tang et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Association of percentage of tumour burden removed with debulking nephrectomy and progression-free survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy
- (2010) Juan Barbastefano et al. BJU INTERNATIONAL
- Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival
- (2010) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- The Impact of Cytoreductive Nephrectomy on Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Targeted Therapy
- (2010) Toni K. Choueiri et al. JOURNAL OF UROLOGY
- Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma
- (2009) Giovanni Lughezzani et al. CANCER
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now